Listed

Biodesix Inc

BDSXNasdaqCIK 1439725HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$26.9m, Q2 FY2026
Operating income−$5.4m, Q2 FY2026
Net income−$7.3m, Q2 FY2026
Biodesix Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m13.5Revenue, Q3 FY2023, three months to 2023-09-30$13.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-01, accession 0000950170-24-119792.Report this figure14.7Revenue, Q4 FY2023, three months to 2023-12-31$14.7m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-03, accession 0000950170-25-030835. Derived: 12-month figure less the 9-month figure.Report this figure14.8Revenue, Q1 FY2024, three months to 2024-03-31$14.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-13, accession 0000950170-25-070339.Report this figure17.9Revenue, Q2 FY2024, three months to 2024-06-30$17.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-07, accession 0000950170-25-105026.Report this figure18.2Revenue, Q3 FY2024, three months to 2024-09-30$18.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure20.4Revenue, Q4 FY2024, three months to 2024-12-31$20.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076547. Derived: 12-month figure less the 9-month figure.Report this figure18.0Revenue, Q1 FY2025, three months to 2025-03-31$18.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure20.0Revenue, Q2 FY2025, three months to 2025-06-30$20.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure21.8Revenue, Q3 FY2025, three months to 2025-09-30$21.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure28.8Revenue, Q4 FY2025, three months to 2025-12-31$28.8m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076547. Derived: 12-month figure less the 9-month figure.Report this figure25.6Revenue, Q1 FY2026, three months to 2026-03-31$25.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure26.9Revenue, Q2 FY2026, three months to 2026-06-30$26.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure
Research and development$m1.9Research and development, Q3 FY2023, three months to 2023-09-30$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-01, accession 0000950170-24-119792.Report this figure1.9Research and development, Q4 FY2023, three months to 2023-12-31$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-03, accession 0000950170-25-030835. Derived: 12-month figure less the 9-month figure.Report this figure2.0Research and development, Q1 FY2024, three months to 2024-03-31$2.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0000950170-25-070339.Report this figure2.6Research and development, Q2 FY2024, three months to 2024-06-30$2.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105026.Report this figure2.5Research and development, Q3 FY2024, three months to 2024-09-30$2.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure2.4Research and development, Q4 FY2024, three months to 2024-12-31$2.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076547. Derived: 12-month figure less the 9-month figure.Report this figure2.9Research and development, Q1 FY2025, three months to 2025-03-31$2.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure3.3Research and development, Q2 FY2025, three months to 2025-06-30$3.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure3.0Research and development, Q3 FY2025, three months to 2025-09-30$3.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure2.9Research and development, Q4 FY2025, three months to 2025-12-31$2.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076547. Derived: 12-month figure less the 9-month figure.Report this figure3.3Research and development, Q1 FY2026, three months to 2026-03-31$3.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure3.1Research and development, Q2 FY2026, three months to 2026-06-30$3.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure
Selling, general and administrative$m15.5Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$15.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-01, accession 0000950170-24-119792.Report this figure16.3Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$16.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-03, accession 0000950170-25-030835. Derived: 12-month figure less the 9-month figure.Report this figure20.6Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$20.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-13, accession 0000950170-25-070339.Report this figure19.7Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$19.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105026.Report this figure20.0Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$20.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure20.2Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$20.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001193125-26-076547. Derived: 12-month figure less the 9-month figure.Report this figure20.4Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$20.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure22.4Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$22.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure21.7Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$21.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure23.0Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$23.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001193125-26-076547. Derived: 12-month figure less the 9-month figure.Report this figure24.3Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$24.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure24.3Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$24.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure
Operating income$m(7.2)Operating income, Q3 FY2023, three months to 2023-09-30−$7.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-01, accession 0000950170-24-119792.Report this figure(6.9)Operating income, Q4 FY2023, three months to 2023-12-31−$6.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-03, accession 0000950170-25-030835. Derived: 12-month figure less the 9-month figure.Report this figure(11.0)Operating income, Q1 FY2024, three months to 2024-03-31−$11.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0000950170-25-070339.Report this figure(8.2)Operating income, Q2 FY2024, three months to 2024-06-30−$8.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105026.Report this figure(8.6)Operating income, Q3 FY2024, three months to 2024-09-30−$8.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure(6.6)Operating income, Q4 FY2024, three months to 2024-12-31−$6.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076547. Derived: 12-month figure less the 9-month figure.Report this figure(9.1)Operating income, Q1 FY2025, three months to 2025-03-31−$9.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure(9.7)Operating income, Q2 FY2025, three months to 2025-06-30−$9.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure(7.1)Operating income, Q3 FY2025, three months to 2025-09-30−$7.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure(2.0)Operating income, Q4 FY2025, three months to 2025-12-31−$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076547. Derived: 12-month figure less the 9-month figure.Report this figure(6.2)Operating income, Q1 FY2026, three months to 2026-03-31−$6.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure(5.4)Operating income, Q2 FY2026, three months to 2026-06-30−$5.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure
Interest expense$m2.4Interest expense, Q3 FY2023, three months to 2023-09-30$2.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-07, accession 0000950170-23-060226.Report this figure2.3Interest expense, Q4 FY2023, three months to 2023-12-31$2.3m. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-03, accession 0000950170-25-030835. Derived: 12-month figure less the 9-month figure.Report this figure2.5Interest expense, Q1 FY2024, three months to 2024-03-31$2.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-13, accession 0000950170-25-070339.Report this figure1.9Interest expense, Q2 FY2024, three months to 2024-06-30$1.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105026.Report this figure2.0Interest expense, Q3 FY2024, three months to 2024-09-30$2.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure1.8Interest expense, Q4 FY2024, three months to 2024-12-31$1.8m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-26, accession 0001193125-26-076547. Derived: 12-month figure less the 9-month figure.Report this figure1.7Interest expense, Q1 FY2025, three months to 2025-03-31$1.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure1.9Interest expense, Q2 FY2025, three months to 2025-06-30$1.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure2.1Interest expense, Q3 FY2025, three months to 2025-09-30$2.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure2.1Interest expense, Q4 FY2025, three months to 2025-12-31$2.1m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-26, accession 0001193125-26-076547. Derived: 12-month figure less the 9-month figure.Report this figure2.0Interest expense, Q1 FY2026, three months to 2026-03-31$2.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure2.0Interest expense, Q2 FY2026, three months to 2026-06-30$2.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2023-11-07, accession 0000950170-23-060226. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2024-03-01, accession 0000950170-24-023513. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-05-08, accession 0000950170-24-055651.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-08-07, accession 0000950170-24-092773. Derived: 6-month figure less the 3-month figure.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-01, accession 0000950170-24-119792. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-03, accession 0000950170-25-030835. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-13, accession 0000950170-25-070339.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0000950170-25-105026. Derived: 6-month figure less the 3-month figure.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-03, accession 0001193125-25-262532. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-076547. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001193125-26-335036. Derived: 6-month figure less the 3-month figure.Report this figure
Net income$m(10.9)Net income, Q3 FY2023, three months to 2023-09-30−$10.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-01, accession 0000950170-24-119792.Report this figure(9.1)Net income, Q4 FY2023, three months to 2023-12-31−$9.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-03, accession 0000950170-25-030835. Derived: 12-month figure less the 9-month figure.Report this figure(13.6)Net income, Q1 FY2024, three months to 2024-03-31−$13.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure(10.8)Net income, Q2 FY2024, three months to 2024-06-30−$10.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure(10.3)Net income, Q3 FY2024, three months to 2024-09-30−$10.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure(8.3)Net income, Q4 FY2024, three months to 2024-12-31−$8.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076547. Derived: 12-month figure less the 9-month figure.Report this figure(11.1)Net income, Q1 FY2025, three months to 2025-03-31−$11.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure(11.5)Net income, Q2 FY2025, three months to 2025-06-30−$11.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure(8.7)Net income, Q3 FY2025, three months to 2025-09-30−$8.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure(4.0)Net income, Q4 FY2025, three months to 2025-12-31−$4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076547. Derived: 12-month figure less the 9-month figure.Report this figure(7.8)Net income, Q1 FY2026, three months to 2026-03-31−$7.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure(7.3)Net income, Q2 FY2026, three months to 2026-06-30−$7.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure
Diluted EPS$ per share(0.14)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-01, accession 0000950170-24-119792.Report this figurenot reported(0.14)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0000950170-25-070339.Report this figure(0.08)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-105026.Report this figure(1.40)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figurenot reported(1.52)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure(1.56)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure(1.16)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figurenot reported(0.81)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure(0.71)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.71 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure
Basic EPS$ per share(0.14)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-01, accession 0000950170-24-119792.Report this figurenot reported(0.14)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0000950170-25-070339.Report this figure(0.08)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-105026.Report this figure(1.40)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figurenot reported(1.52)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure(1.56)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.56 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure(1.16)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figurenot reported(0.81)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.81 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure(0.71)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.71 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure

Balance sheet

Cash and equivalents$30.0m, Q2 FY2026
Long-term debt$50.0m, Q2 FY2026
Shareholders' equity$9.1m, Q2 FY2026
Biodesix Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m19.8Cash and equivalents, Q3 FY2023, at 2023-09-30$19.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-07, accession 0000950170-23-060226.Report this figure26.3Cash and equivalents, FY2023, at 2023-12-31$26.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-03, accession 0000950170-25-030835.Report this figure11.5Cash and equivalents, Q1 FY2024, at 2024-03-31$11.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0000950170-24-055651.Report this figure42.2Cash and equivalents, Q2 FY2024, at 2024-06-30$42.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-07, accession 0000950170-24-092773.Report this figure31.4Cash and equivalents, Q3 FY2024, at 2024-09-30$31.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-01, accession 0000950170-24-119792.Report this figure26.2Cash and equivalents, FY2024, at 2024-12-31$26.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001193125-26-076547.Report this figure17.6Cash and equivalents, Q1 FY2025, at 2025-03-31$17.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0000950170-25-070339.Report this figure20.7Cash and equivalents, Q2 FY2025, at 2025-06-30$20.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-105026.Report this figure16.6Cash and equivalents, Q3 FY2025, at 2025-09-30$16.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure19.0Cash and equivalents, FY2025, at 2025-12-31$19.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure25.6Cash and equivalents, Q1 FY2026, at 2026-03-31$25.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure30.0Cash and equivalents, Q2 FY2026, at 2026-06-30$30.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure
Current assets$m28.9Current assets, Q3 FY2023, at 2023-09-30$28.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0000950170-23-060226.Report this figure39.7Current assets, FY2023, at 2023-12-31$39.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-03, accession 0000950170-25-030835.Report this figure28.5Current assets, Q1 FY2024, at 2024-03-31$28.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055651.Report this figure57.6Current assets, Q2 FY2024, at 2024-06-30$57.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0000950170-24-092773.Report this figure44.0Current assets, Q3 FY2024, at 2024-09-30$44.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-01, accession 0000950170-24-119792.Report this figure39.5Current assets, FY2024, at 2024-12-31$39.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001193125-26-076547.Report this figure29.6Current assets, Q1 FY2025, at 2025-03-31$29.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070339.Report this figure32.4Current assets, Q2 FY2025, at 2025-06-30$32.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105026.Report this figure33.4Current assets, Q3 FY2025, at 2025-09-30$33.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure32.5Current assets, FY2025, at 2025-12-31$32.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure40.9Current assets, Q1 FY2026, at 2026-03-31$40.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure43.6Current assets, Q2 FY2026, at 2026-06-30$43.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure
Total assets$m86.8Total assets, Q3 FY2023, at 2023-09-30$86.8m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0000950170-23-060226.Report this figure99.1Total assets, FY2023, at 2023-12-31$99.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-03, accession 0000950170-25-030835.Report this figure87.2Total assets, Q1 FY2024, at 2024-03-31$87.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0000950170-24-055651.Report this figure116Total assets, Q2 FY2024, at 2024-06-30$115.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0000950170-24-092773.Report this figure103Total assets, Q3 FY2024, at 2024-09-30$102.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-01, accession 0000950170-24-119792.Report this figure97.2Total assets, FY2024, at 2024-12-31$97.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001193125-26-076547.Report this figure86.2Total assets, Q1 FY2025, at 2025-03-31$86.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0000950170-25-070339.Report this figure87.7Total assets, Q2 FY2025, at 2025-06-30$87.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-105026.Report this figure88.7Total assets, Q3 FY2025, at 2025-09-30$88.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure87.5Total assets, FY2025, at 2025-12-31$87.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure94.6Total assets, Q1 FY2026, at 2026-03-31$94.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure95.3Total assets, Q2 FY2026, at 2026-06-30$95.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure
Current liabilities$m32.6Current liabilities, Q3 FY2023, at 2023-09-30$32.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0000950170-23-060226.Report this figure33.4Current liabilities, FY2023, at 2023-12-31$33.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-03, accession 0000950170-25-030835.Report this figure31.2Current liabilities, Q1 FY2024, at 2024-03-31$31.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055651.Report this figure17.6Current liabilities, Q2 FY2024, at 2024-06-30$17.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0000950170-24-092773.Report this figure13.0Current liabilities, Q3 FY2024, at 2024-09-30$13.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-01, accession 0000950170-24-119792.Report this figure14.3Current liabilities, FY2024, at 2024-12-31$14.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001193125-26-076547.Report this figure13.3Current liabilities, Q1 FY2025, at 2025-03-31$13.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070339.Report this figure15.2Current liabilities, Q2 FY2025, at 2025-06-30$15.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105026.Report this figure18.2Current liabilities, Q3 FY2025, at 2025-09-30$18.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure17.4Current liabilities, FY2025, at 2025-12-31$17.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure14.5Current liabilities, Q1 FY2026, at 2026-03-31$14.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure15.3Current liabilities, Q2 FY2026, at 2026-06-30$15.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure
Total liabilities$m88.2Total liabilities, Q3 FY2023, at 2023-09-30$88.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0000950170-23-060226.Report this figure94.5Total liabilities, FY2023, at 2023-12-31$94.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-03, accession 0000950170-25-030835.Report this figure92.7Total liabilities, Q1 FY2024, at 2024-03-31$92.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0000950170-24-055651.Report this figure79.6Total liabilities, Q2 FY2024, at 2024-06-30$79.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0000950170-24-092773.Report this figure74.9Total liabilities, Q3 FY2024, at 2024-09-30$74.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-01, accession 0000950170-24-119792.Report this figure76.4Total liabilities, FY2024, at 2024-12-31$76.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001193125-26-076547.Report this figure75.2Total liabilities, Q1 FY2025, at 2025-03-31$75.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0000950170-25-070339.Report this figure86.6Total liabilities, Q2 FY2025, at 2025-06-30$86.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-105026.Report this figure90.4Total liabilities, Q3 FY2025, at 2025-09-30$90.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure89.9Total liabilities, FY2025, at 2025-12-31$89.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure85.5Total liabilities, Q1 FY2026, at 2026-03-31$85.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure86.2Total liabilities, Q2 FY2026, at 2026-06-30$86.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure
Long-term debt$m30.1Long-term debt, Q3 FY2023, at 2023-09-30$30.1m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-07, accession 0000950170-23-060226.Report this figure40.1Long-term debt, FY2023, at 2023-12-31$40.1m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2024-03-01, accession 0000950170-24-023513.Report this figure40.1Long-term debt, Q1 FY2024, at 2024-03-31$40.1m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-05-08, accession 0000950170-24-055651.Report this figure40.1Long-term debt, Q2 FY2024, at 2024-06-30$40.1m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-08-07, accession 0000950170-24-092773.Report this figure40.0Long-term debt, Q3 FY2024, at 2024-09-30$40.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-11-01, accession 0000950170-24-119792.Report this figure40.0Long-term debt, FY2024, at 2024-12-31$40.0m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-03-03, accession 0000950170-25-030835.Report this figure40.0Long-term debt, Q1 FY2025, at 2025-03-31$40.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-05-13, accession 0000950170-25-070339.Report this figure50.0Long-term debt, Q2 FY2025, at 2025-06-30$50.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-08-07, accession 0000950170-25-105026.Report this figure50.0Long-term debt, Q3 FY2025, at 2025-09-30$50.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure50.0Long-term debt, FY2025, at 2025-12-31$50.0m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-02-26, accession 0001193125-26-076547.Report this figure50.0Long-term debt, Q1 FY2026, at 2026-03-31$50.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure50.0Long-term debt, Q2 FY2026, at 2026-06-30$50.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure
Shareholders' equity$m(1.4)Shareholders' equity, Q3 FY2023, at 2023-09-30−$1.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-01, accession 0000950170-24-119792.Report this figure4.6Shareholders' equity, FY2023, at 2023-12-31$4.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001193125-26-076547.Report this figure(5.5)Shareholders' equity, Q1 FY2024, at 2024-03-31−$5.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure36.3Shareholders' equity, Q2 FY2024, at 2024-06-30$36.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure27.9Shareholders' equity, Q3 FY2024, at 2024-09-30$27.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure20.9Shareholders' equity, FY2024, at 2024-12-31$20.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure11.1Shareholders' equity, Q1 FY2025, at 2025-03-31$11.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure1.1Shareholders' equity, Q2 FY2025, at 2025-06-30$1.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure(1.7)Shareholders' equity, Q3 FY2025, at 2025-09-30−$1.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure(2.5)Shareholders' equity, FY2025, at 2025-12-31−$2.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure9.1Shareholders' equity, Q1 FY2026, at 2026-03-31$9.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure9.1Shareholders' equity, Q2 FY2026, at 2026-06-30$9.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure

Cash flow

Operating cash flow−$1.6m, Q2 FY2026
Capital expenditure$197.0k, Q2 FY2026
Biodesix Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(3.8)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-01, accession 0000950170-24-119792. Derived: 9-month figure less the 6-month figure.Report this figure(12.3)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$12.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-03, accession 0000950170-25-030835. Derived: 12-month figure less the 9-month figure.Report this figure(15.3)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$15.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0000950170-25-070339.Report this figure(18.6)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$18.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-105026. Derived: 6-month figure less the 3-month figure.Report this figure(10.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$10.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001193125-25-262532. Derived: 9-month figure less the 6-month figure.Report this figure(4.1)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$4.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076547. Derived: 12-month figure less the 9-month figure.Report this figure(8.6)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$8.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure(6.6)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$6.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-335036. Derived: 6-month figure less the 3-month figure.Report this figure(8.9)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$8.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001193125-25-262532. Derived: 9-month figure less the 6-month figure.Report this figure0.8Operating cash flow, Q4 FY2025, three months to 2025-12-31$778.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076547. Derived: 12-month figure less the 9-month figure.Report this figure(10.2)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$10.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure(1.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-335036. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m5.8Capital expenditure, Q3 FY2023, three months to 2023-09-30$5.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-01, accession 0000950170-24-119792. Derived: 9-month figure less the 6-month figure.Report this figure3.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$3.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-03, accession 0000950170-25-030835. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2024, three months to 2024-03-31$234.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0000950170-25-070339.Report this figure1.9Capital expenditure, Q2 FY2024, three months to 2024-06-30$1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-105026. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$231.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-03, accession 0001193125-25-262532. Derived: 9-month figure less the 6-month figure.Report this figure0.8Capital expenditure, Q4 FY2024, three months to 2024-12-31$839.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076547. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$74.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$51.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001193125-26-335036. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$48.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-03, accession 0001193125-25-262532. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$86.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076547. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$81.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure0.2Capital expenditure, Q2 FY2026, three months to 2026-06-30$197.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001193125-26-335036. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)10.30m, Q2 FY2026
Biodesix Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares40.4Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3040,448,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0000950170-23-060226.Report this figure77.8Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3177,765,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0000950170-24-055651.Report this figure78.5Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3078,506,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0000950170-24-092773.Report this figure79.7Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3079,709,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-01, accession 0000950170-24-119792.Report this figure97.2Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3197,166,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0000950170-25-070339.Report this figure127Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30127,168,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-105026.Report this figure7.3Diluted shares (weighted), Q3 FY2024, three months to 2024-09-307,315,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure7.3Diluted shares (weighted), Q1 FY2025, three months to 2025-03-317,300,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure7.3Diluted shares (weighted), Q2 FY2025, three months to 2025-06-307,333,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure7.5Diluted shares (weighted), Q3 FY2025, three months to 2025-09-307,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0001193125-25-262532.Report this figure9.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-319,656,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-04, accession 0001193125-26-203960.Report this figure10.3Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3010,296,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure

Shares outstanding: 10.55mShares outstanding, period not labelled, at 2026-07-3010,551,118 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335036.Report this figure at Jul 30, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. Listed shows no prices and gives no investment advice.